Inducible expression of Runx2 results in multiorgan abnormalities in mice.
Runx2 is a transcription factor controlling skeletal development, and is also expressed in extraskeletal tissues where its function is not well understood. Existing Runx2 mutant and transgenic mouse models do not allow the necessary control of Runx2 expression to understand its functions in different tissues. We generated conditional, doxycyline-inducible, triple transgenic mice (CMV-Cre;ROSA26-neo(flox/+)-rtTA;Tet-O-Runx2) to investigate the effects of wide spread overexpression of Runx2. Osteoblasts isolated from CMV-Cre;ROSA26-neo(flox/+)-rtTA; Tet-O-Runx2 mice demonstrated a dose-dependent effect of doxycycline to stimulate Runx2 transgene expression. Doxycycline administration to CMV-Cre;ROSA26-neo(flox/+)-rtTA;Tet-O-Runx2 mice induced Runx2 transgene expression in all tissues tested, with the highest levels observed in kidney, ovary, and bone. Runx2 overexpression resulted in deceased body size and reduced viability. With regard to bone, Runx2 overexpressing mice paradoxically displayed profound osteopenia and diminished osteogenesis. Induced expression of Runx2 in extraskeletal tissues resulted in ectopic calcification and induction of the osteogenic program in a limited number of tissues, including lung and muscle. In addition, the triple transgenic mice showed evidence of a myeloproliferative disorder and an apparent inhibition of lymphocyte development. Thus, overexpression of Runx2 both within and outside of the skeleton can have diverse biological effects. Use of tissue specific Cre mice will allow this model to be used to conditionally and inducibly overexpress Runx2 in different tissues and provide a means to study the post-natal tissue- and cell context-dependent functions of Runx2.
The Kidney Institute, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
Nan
N
He
Zhousheng
Z
Xiao
Tong
T
Yin
Jason
J
Stubbs
Linheng
L
Li
L Darryl
LD
Quarles
D000818:Animals; D001853:Bone Marrow / Q000002:abnormalities / Q000378:metabolism; D002478:Cells, Cultured; D050659:Core Binding Factor Alpha 1 Subunit / Q000235:genetics / Q000378:metabolism*; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D008099:Liver / Q000002:abnormalities / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D009139:Musculoskeletal Abnormalities / Q000235:genetics / Q000378:metabolism; D010641:Phenotype; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013154:Spleen / Q000002:abnormalities / Q000378:metabolism; D013950:Thymus Gland / Q000002:abnormalities / Q000378:metabolism
D050659:Core Binding Factor Alpha 1 Subunit
Dev Dyn. 2007 Jul;236(7):1876-90
17497678
J Biol Chem. 2006 Oct 13;281(41):30884-95
16905538
Circ Res. 2009 Mar 27;104(6):733-41
19197075
J Am Soc Nephrol. 2008 Jun;19(6):1092-105
18417722
Oncogene. 1999 Nov 25;18(50):7124-34
10597314
Oncogene. 1996 Jul 18;13(2):303-12
8710369
Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8646-51
9238031
J Cell Biol. 2001 Apr 2;153(1):87-100
11285276
Endocrinology. 2001 Sep;142(9):4026-39
11517182
Nucleic Acids Res. 2005 Mar 22;33(5):e51
15784609
Cell. 1997 May 30;89(5):765-71
9182764
Cell. 1997 May 30;89(5):747-54
9182762
Genes Dev. 1998 May 1;12(9):1260-8
9573043
Cancer Sci. 2003 Oct;94(10):841-6
14556655
J Biol Chem. 2006 Dec 29;281(52):40515-26
17060321
Science. 2006 May 26;312(5777):1223-7
16728642
J Am Soc Nephrol. 2007 Jul;18(7):2116-24
17554146
Oncogene. 2004 Jun 10;23(27):4722-34
15107836
Crit Rev Eukaryot Gene Expr. 2005;15(3):243-54
16390320
Biochem Biophys Res Commun. 1998 Nov 27;252(3):582-9
9837750
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6859-63
8341710
J Bone Miner Res. 2009 Nov;24(11):1889-904
19419310
Dev Biol. 2007 Apr 1;304(1):420-32
17250821
J Cell Biochem. 1997 Jul 1;66(1):123-32
9215534
Nature. 2006 May 25;441(7092):518-22
16633340
Gene. 1996 Feb 12;168(2):279-80
8654962
J Cell Biol. 2001 Oct 1;155(1):157-66
11581292
Cancer Res. 2006 Feb 15;66(4):2195-201
16489021
J Bone Miner Res. 2005 Sep;20(9):1624-36
16059634
Dev Biol. 2005 Jul 15;283(2):345-56
15936013
J Cell Biochem. 1999 Sep 15;74(4):596-605
10440929
J Cell Biochem. 2010 Jul 1;110(4):935-47
20564193
Bone. 2008 Sep;43(3):427-33
18590993
J Biol Chem. 2006 Mar 17;281(11):7118-28
16407259
Dev Cell. 2005 May;8(5):751-64
15866165
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1454-9
15665096
J Cell Sci. 2000 Jun;113 ( Pt 12):2221-31
10825294
Mol Cell Biol. 1995 Mar;15(3):1662-70
7862157
Am J Pathol. 2007 May;170(5):1676-85
17456773
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8650-5
11438701
Cell Cycle. 2004 Jun;3(6):722-4
15213471
Oncogene. 2001 Jan 18;20(3):295-302
11313958
Leukemia. 2005 Dec;19(12):2166-76
16208410
Mol Cell Biol. 1998 Jul;18(7):4197-208
9632804
Genes Dev. 1999 Apr 15;13(8):1025-36
10215629
J Cell Biochem. 2010 Mar 1;109(4):828-37
20082326
Blood. 2009 Apr 2;113(14):3323-32
19179305
Gene Ther. 2006 Jun;13(11):873-82
16496016
Dev Biol. 2006 Aug 1;296(1):48-61
16797526
Respir Med. 2000 Mar;94(3):190-3
10783928
J Cell Sci. 2001 Sep;114(Pt 17):3093-102
11590236
J Biol Chem. 2004 May 7;279(19):20307-13
15007057
Cell. 1997 May 30;89(5):755-64
9182763
J Cell Biochem. 2006 Oct 1;99(2):545-57
16639721
Ann Pharm Fr. 2009 Jul;67(4):234-40
19596096
Nat Med. 2004 Mar;10(3):299-304
14966519
J Biol Chem. 2000 Mar 24;275(12):8695-702
10722711
J Biol Chem. 2008 May 30;283(22):15319-27
18378684
Mol Cell Biol. 2002 Sep;22(17):6222-33
12167715
Am J Hum Genet. 1999 Nov;65(5):1268-78
10521292
J Bone Miner Res. 2006 Feb;21(2):265-73
16418782
Nat Rev Cancer. 2005 May;5(5):376-87
15864279
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3444-9
8622955